These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27741283)
1. Data Mining of Lung Microbiota in Cystic Fibrosis Patients. Li J; Hao C; Ren L; Xiao Y; Wang J; Qin X PLoS One; 2016; 11(10):e0164510. PubMed ID: 27741283 [TBL] [Abstract][Full Text] [Related]
2. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period. de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R mBio; 2017 Sep; 8(5):. PubMed ID: 28951476 [TBL] [Abstract][Full Text] [Related]
3. Divergence of bacterial communities in the lower airways of CF patients in early childhood. O'Connor JB; Mottlowitz MM; Wagner BD; Boyne KL; Stevens MJ; Robertson CE; Harris JK; Laguna TA PLoS One; 2021; 16(10):e0257838. PubMed ID: 34613995 [TBL] [Abstract][Full Text] [Related]
4. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum. Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714 [TBL] [Abstract][Full Text] [Related]
5. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765 [TBL] [Abstract][Full Text] [Related]
6. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease. Hogan DA; Willger SD; Dolben EL; Hampton TH; Stanton BA; Morrison HG; Sogin ML; Czum J; Ashare A PLoS One; 2016; 11(3):e0149998. PubMed ID: 26943329 [TBL] [Abstract][Full Text] [Related]
7. Decade-long bacterial community dynamics in cystic fibrosis airways. Zhao J; Schloss PD; Kalikin LM; Carmody LA; Foster BK; Petrosino JF; Cavalcoli JD; VanDevanter DR; Murray S; Li JZ; Young VB; LiPuma JJ Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5809-14. PubMed ID: 22451929 [TBL] [Abstract][Full Text] [Related]
8. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability. Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187 [No Abstract] [Full Text] [Related]
9. Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome. Nelson MT; Wolter DJ; Eng A; Weiss EJ; Vo AT; Brittnacher MJ; Hayden HS; Ravishankar S; Bautista G; Ratjen A; Blackledge M; McNamara S; Nay L; Majors C; Miller SI; Borenstein E; Simon RH; LiPuma JJ; Hoffman LR Thorax; 2020 Sep; 75(9):780-790. PubMed ID: 32631930 [TBL] [Abstract][Full Text] [Related]
10. Lung function and microbiota diversity in cystic fibrosis. Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195 [TBL] [Abstract][Full Text] [Related]
12. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation. Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536 [TBL] [Abstract][Full Text] [Related]
13. The altered gut microbiota in adults with cystic fibrosis. Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152 [TBL] [Abstract][Full Text] [Related]
14. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention. Cuthbertson L; Rogers GB; Walker AW; Oliver A; Green LE; Daniels TW; Carroll MP; Parkhill J; Bruce KD; van der Gast CJ ISME J; 2016 May; 10(5):1081-91. PubMed ID: 26555248 [TBL] [Abstract][Full Text] [Related]
15. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis. Carmody LA; Caverly LJ; Foster BK; Rogers MAM; Kalikin LM; Simon RH; VanDevanter DR; LiPuma JJ PLoS One; 2018; 13(3):e0194060. PubMed ID: 29522532 [TBL] [Abstract][Full Text] [Related]
16. Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis. Carmody LA; Kalikin LM; VanDevanter DR; Li G; Opron K; Simon RH; Caverly LJ; LiPuma JJ J Cyst Fibros; 2022 Sep; 21(5):766-768. PubMed ID: 35667975 [TBL] [Abstract][Full Text] [Related]
17. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period. Stokell JR; Gharaibeh RZ; Hamp TJ; Zapata MJ; Fodor AA; Steck TR J Clin Microbiol; 2015 Jan; 53(1):237-47. PubMed ID: 25392361 [TBL] [Abstract][Full Text] [Related]
18. Testing the neutral theory of biodiversity with the microbiome dataset from cystic fibrosis patients. Huang Q; Wang Y; Xia Y; Li L; Luo J; Xia S; Sun Y; Miao Y; Wang K; Chen Y Medicine (Baltimore); 2018 Sep; 97(37):e12248. PubMed ID: 30212959 [TBL] [Abstract][Full Text] [Related]
19. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782 [TBL] [Abstract][Full Text] [Related]